A hepatitis-free future: strategy first, then pricing

Lancet Infect Dis. 2016 Apr;16(4):399-400. doi: 10.1016/S1473-3099(16)00126-2.

Authors

Heidi J Larson¹, Pierre Van Damme², David FitzSimons³

Affiliations

¹ London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK; University of Washington, Seattle, WA, USA. Electronic address: Heidi.Larson@lshtm.ac.uk.
² University of Antwerp, Antwerp, Belgium.
³ Independent researcher, Prévessin-Moens, France.

PMID: 27036336
DOI: 10.1016/S1473-3099(16)00126-2

No abstract available

MeSH terms

Global Health*
Hepatitis, Viral, Human / economics*
Hepatitis, Viral, Human / prevention & control*
Hepatitis, Viral, Human / virology
Humans